Insider Trades133 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Sell | ARDX | Michael Raab | President & CEO | 62,502 | $3.70 | $892.1M | -57.38% | +0.56% | $231.5K | -0.56% | 10b5-1 | Sell Now |
| Jun 18, 2026 | Sell | ARDX | Laura A Williams | Chief Patient Officer | 112,898 | $4.62 | $892.1M | -57.38% | +0.56% | $521.2K | -5.53% | 10b5-1 | Sell Now |
| Jun 15, 2026 | Sell | ARDX | Michael Raab | President & CEO | 62,499 | $4.11 | $892.1M | -57.38% | +0.56% | $257.0K | -0.55% | 10b5-1 | Sell Now |
| May 21, 2026 | Sell | ARDX | Susan Hohenleitner | Chief Financial Officer | 1,455 | $6.27 | $892.1M | -57.38% | +0.56% | $9.1K | -0.63% | — | Sell Now |
| May 21, 2026 | Sell | ARDX | James Parker Brady | Chief Human Resources Officer | 1,846 | $6.27 | $892.1M | -57.38% | +0.56% | $11.6K | -0.70% | — | Sell Now |
| May 21, 2026 | Sell | ARDX | John E Bishop | — | 2,306 | $6.27 | $892.1M | -57.38% | +0.56% | $14.5K | -0.68% | — | Sell Now |
| May 21, 2026 | Sell | ARDX | Joseph James Reilly | — | 3,719 | $6.27 | $892.1M | -57.38% | +0.56% | $23.3K | -1.23% | — | Sell Now |
| May 21, 2026 | Sell | ARDX | Laura A Williams | Chief Patient Officer | 6,989 | $6.27 | $892.1M | -57.38% | +0.56% | $43.8K | -0.40% | — | Sell Now |
| May 21, 2026 | Sell | ARDX | Mike Kelliher | Chief Business Officer | 7,248 | $6.27 | $892.1M | -57.38% | +0.56% | $45.4K | -0.67% | — | Sell Now |
| May 21, 2026 | Sell | ARDX | Eric Duane Foster | Chief Commercial Officer | 7,998 | $6.27 | $892.1M | -57.38% | +0.56% | $50.1K | -0.63% | — | Sell Now |
| May 21, 2026 | Sell | ARDX | Michael Raab | President & CEO | 54,748 | $6.27 | $892.1M | -57.38% | +0.56% | $343.1K | -0.78% | — | Sell Now |
| May 15, 2026 | Sell | ARDX | Michael Raab | President & CEO | 62,499 | $4.52 | $892.1M | -57.38% | +0.56% | $282.2K | -0.53% | 10b5-1 | Sell Now |
| Apr 15, 2026 | Sell | ARDX | Michael Raab | President & CEO | 62,502 | $4.52 | $892.1M | -57.38% | +0.56% | $282.6K | -0.52% | 10b5-1 | Sell Now |
| Mar 16, 2026 | Sell | ARDX | Michael Raab | President & CEO | 62,499 | $4.22 | $892.1M | -57.38% | +0.56% | $264.0K | -0.51% | 10b5-1 | Sell Now |
| Feb 24, 2026 | Sell | ARDX | Michael Raab | President & CEO | 62,499 | $4.50 | $892.1M | -57.38% | +0.56% | $281.2K | -0.50% | 10b5-1 | Sell Now |
| Feb 20, 2026 | Sell | ARDX | Susan Hohenleitner | Chief Financial Officer | 2,033 | $5.85 | $892.1M | -57.38% | +0.56% | $11.9K | -0.44% | — | Sell Now |
| Feb 20, 2026 | Sell | ARDX | James Parker Brady | Chief Human Resources Officer | 2,543 | $5.85 | $892.1M | -57.38% | +0.56% | $14.9K | -0.48% | — | Sell Now |
| Feb 20, 2026 | Sell | ARDX | John E Bishop | — | 3,179 | $5.85 | $892.1M | -57.38% | +0.56% | $18.6K | -0.31% | — | Sell Now |
| Feb 20, 2026 | Sell | ARDX | Joseph James Reilly | — | 4,991 | $5.85 | $892.1M | -57.38% | +0.56% | $29.2K | -1.08% | — | Sell Now |
| Feb 20, 2026 | Sell | ARDX | Laura A Williams | — | 8,176 | $5.85 | $892.1M | -57.38% | +0.56% | $47.8K | -0.93% | — | Sell Now |
| Feb 20, 2026 | Sell | ARDX | Mike Kelliher | — | 9,595 | $5.85 | $892.1M | -57.38% | +0.56% | $56.1K | -0.87% | — | Sell Now |
| Feb 20, 2026 | Sell | ARDX | Eric Duane Foster | Chief Commercial Officer | 10,439 | $5.85 | $892.1M | -57.38% | +0.56% | $61.0K | -0.61% | — | Sell Now |
| Feb 20, 2026 | Sell | ARDX | Michael Raab | President & CEO | 45,982 | $5.85 | $892.1M | -57.38% | +0.56% | $268.8K | -0.49% | — | Sell Now |
| Jan 8, 2026 | Sell | ARDX | Laura A Williams | Chief Patient Officer | 100,000 | $3.98 | $892.1M | -57.38% | +0.56% | $398.4K | +0.00% | — | Sell Now |
| Nov 21, 2025 | Sell | ARDX | Mike Kelliher | — | 5,560 | $5.54 | $892.1M | -57.38% | +0.56% | $30.8K | -2.01% | — | Sell Now |
| Nov 21, 2025 | Sell | ARDX | Eric Duane Foster | Chief Commercial Officer | 5,814 | $5.54 | $892.1M | -57.38% | +0.56% | $32.2K | -1.93% | — | Sell Now |
| Nov 21, 2025 | Sell | ARDX | Elizabeth A Grammer | — | 5,995 | $5.54 | $892.1M | -57.38% | +0.56% | $33.2K | -1.96% | — | Sell Now |
| Nov 21, 2025 | Sell | ARDX | Laura A Williams | Chief Patient Officer | 6,426 | $5.54 | $892.1M | -57.38% | +0.56% | $35.6K | -1.75% | — | Sell Now |
| Nov 21, 2025 | Sell | ARDX | Joseph James Reilly | — | 11,086 | $5.54 | $892.1M | -57.38% | +0.56% | $61.4K | -9.24% | — | Sell Now |
| Nov 21, 2025 | Sell | ARDX | Michael Raab | President & CEO | 46,887 | $5.54 | $892.1M | -57.38% | +0.56% | $259.6K | -3.12% | — | Sell Now |
| Aug 26, 2025 | Sell | ARDX | Laura A Williams | Chief Patient Officer | 130,000 | $4.15 | $892.1M | -57.38% | +0.56% | $539.2K | -2.22% | — | Sell Now |
| Aug 21, 2025 | Sell | ARDX | Mike Kelliher | Chief Business Officer | 5,417 | $5.93 | $892.1M | -57.38% | +0.56% | $32.1K | -1.92% | — | Sell Now |
| Aug 21, 2025 | Sell | ARDX | Elizabeth A Grammer | — | 5,841 | $5.93 | $892.1M | -57.38% | +0.56% | $34.6K | -1.87% | — | Sell Now |
| Aug 21, 2025 | Sell | ARDX | Laura A Williams | Chief Patient Officer | 6,261 | $5.93 | $892.1M | -57.38% | +0.56% | $37.1K | -1.56% | — | Sell Now |
| Aug 21, 2025 | Sell | ARDX | Justin A Renz | Chief Financial Officer | 7,037 | $5.93 | $892.1M | -57.38% | +0.56% | $41.7K | -1.69% | — | Sell Now |
| Aug 21, 2025 | Sell | ARDX | Eric Duane Foster | Chief Commercial Officer | 15,308 | $5.93 | $892.1M | -57.38% | +0.56% | $90.8K | -4.83% | — | Sell Now |
| Aug 21, 2025 | Sell | ARDX | Michael Raab | President & CEO | 45,687 | $5.93 | $892.1M | -57.38% | +0.56% | $271.0K | -2.95% | — | Sell Now |
| May 20, 2025 | Sell | ARDX | Eric Duane Foster | Chief Commercial Officer | 2,507 | $4.08 | $892.1M | -57.38% | +0.56% | $10.2K | -0.79% | — | Sell Now |
| May 20, 2025 | Sell | ARDX | Elizabeth A Grammer | — | 5,992 | $4.08 | $892.1M | -57.38% | +0.56% | $24.5K | -1.89% | — | Sell Now |
| May 20, 2025 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 6,421 | $4.08 | $892.1M | -57.38% | +0.56% | $26.2K | -1.57% | — | Sell Now |
| May 20, 2025 | Sell | ARDX | Justin A Renz | Chief Financial Officer | 7,218 | $4.08 | $892.1M | -57.38% | +0.56% | $29.5K | -1.71% | — | Sell Now |
| May 20, 2025 | Sell | ARDX | Mike Kelliher | — | 14,522 | $4.08 | $892.1M | -57.38% | +0.56% | $59.3K | -4.89% | — | Sell Now |
| May 20, 2025 | Sell | ARDX | Michael Raab | President & CEO | 46,817 | $4.08 | $892.1M | -57.38% | +0.56% | $191.1K | -2.94% | — | Sell Now |
| May 2, 2025 | Sell | ARDX | Michael Raab | President & CEO | 62,499 | $3.16 | $892.1M | -57.38% | +0.56% | $197.8K | -0.57% | 10b5-1 | Sell Now |
| Apr 4, 2025 | Sell | ARDX | Michael Raab | President & CEO | 62,499 | $3.39 | $892.1M | -57.38% | +0.56% | $211.8K | -0.56% | 10b5-1 | Sell Now |
| Mar 7, 2025 | Sell | ARDX | Michael Raab | President & CEO | 62,502 | $3.90 | $892.1M | -57.38% | +0.56% | $243.8K | -0.55% | 10b5-1 | Sell Now |
| Feb 20, 2025 | Sell | ARDX | Elizabeth A Grammer | — | 4,291 | $5.62 | $892.1M | -57.38% | +0.56% | $24.1K | -2.32% | — | Sell Now |
| Feb 20, 2025 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 4,941 | $5.62 | $892.1M | -57.38% | +0.56% | $27.8K | -1.60% | — | Sell Now |
| Feb 20, 2025 | Sell | ARDX | Justin A Renz | Chief Financial Officer | 5,171 | $5.62 | $892.1M | -57.38% | +0.56% | $29.1K | -1.78% | — | Sell Now |
| Feb 20, 2025 | Sell | ARDX | Michael Raab | President & CEO | 22,964 | $5.62 | $892.1M | -57.38% | +0.56% | $129.1K | -2.07% | — | Sell Now |
| Jan 31, 2025 | Sell | ARDX | Michael Raab | President & CEO | 62,499 | $3.90 | $892.1M | -57.38% | +0.56% | $244.0K | -0.76% | 10b5-1 | Sell Now |
| Jan 7, 2025 | Sell | ARDX | Michael Raab | President & CEO | 62,499 | $3.87 | $892.1M | -57.38% | +0.56% | $241.9K | -0.74% | 10b5-1 | Sell Now |
| Dec 10, 2024 | Sell | ARDX | Michael Raab | President & CEO | 50,000 | $3.13 | $892.1M | -57.38% | +0.56% | $156.4K | +0.00% | 10b5-1 | Sell Now |
| Nov 25, 2024 | Sell | ARDX | Michael Raab | President & CEO | 25,000 | $5.38 | $892.1M | -57.38% | +0.56% | $134.5K | -2.13% | 10b5-1 | Sell Now |
| Nov 20, 2024 | Sell | ARDX | Robert Blanks | — | 4,941 | $4.79 | $892.1M | -57.38% | +0.56% | $23.7K | -1.55% | — | Sell Now |
| Nov 20, 2024 | Sell | ARDX | Justin A Renz | Chief Financial Officer | 5,260 | $4.79 | $892.1M | -57.38% | +0.56% | $25.2K | -1.77% | — | Sell Now |
| Nov 20, 2024 | Sell | ARDX | Elizabeth A Grammer | — | 7,046 | $4.79 | $892.1M | -57.38% | +0.56% | $33.8K | -3.66% | — | Sell Now |
| Nov 20, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 7,184 | $4.79 | $892.1M | -57.38% | +0.56% | $34.4K | -1.58% | — | Sell Now |
| Nov 20, 2024 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 7,366 | $4.79 | $892.1M | -57.38% | +0.56% | $35.3K | -2.33% | — | Sell Now |
| Nov 20, 2024 | Sell | ARDX | Michael Raab | President & CEO | 31,980 | $4.79 | $892.1M | -57.38% | +0.56% | $153.3K | -2.65% | — | Sell Now |
| Nov 11, 2024 | Sell | ARDX | Michael Raab | President & CEO | 2,743 | $4.90 | $892.1M | -57.38% | +0.56% | $13.4K | -0.23% | 10b5-1 | Sell Now |
| Nov 6, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 54,342 | $4.21 | $892.1M | -57.38% | +0.56% | $228.8K | +0.00% | — | Sell Now |
| Nov 4, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 54,344 | $4.13 | $892.1M | -57.38% | +0.56% | $224.7K | +0.00% | — | Sell Now |
| Oct 28, 2024 | Sell | ARDX | Michael Raab | President & CEO | 50,000 | $3.45 | $892.1M | -57.38% | +0.56% | $172.5K | +0.00% | 10b5-1 | Sell Now |
| Oct 11, 2024 | Sell | ARDX | Michael Raab | President & CEO | 7,500 | $6.01 | $892.1M | -57.38% | +0.56% | $45.1K | -0.62% | 10b5-1 | Sell Now |
| Sep 27, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 49,564 | $6.92 | $892.1M | -57.38% | +0.56% | $343.0K | -14.10% | 10b5-1 | Sell Now |
| Sep 26, 2024 | Sell | ARDX | Michael Raab | President & CEO | 3,000 | $6.07 | $892.1M | -57.38% | +0.56% | $18.2K | -0.25% | 10b5-1 | Sell Now |
| Sep 13, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 5,312 | $6.26 | $892.1M | -57.38% | +0.56% | $33.3K | -3.34% | — | Sell Now |
| Sep 11, 2024 | Sell | ARDX | Michael Raab | President & CEO | 70,000 | $3.30 | $892.1M | -57.38% | +0.56% | $231.0K | +0.00% | 10b5-1 | Sell Now |
| Aug 27, 2024 | Sell | ARDX | Michael Raab | President & CEO | 7,500 | $6.22 | $892.1M | -57.38% | +0.56% | $46.6K | -0.61% | 10b5-1 | Sell Now |
| Aug 20, 2024 | Sell | ARDX | Robert Ora Felsch | — | 3,567 | $5.86 | $892.1M | -57.38% | +0.56% | $20.9K | -3.75% | — | Sell Now |
| Aug 20, 2024 | Sell | ARDX | Robert Blanks | — | 4,969 | $5.86 | $892.1M | -57.38% | +0.56% | $29.1K | -1.53% | — | Sell Now |
| Aug 20, 2024 | Sell | ARDX | Justin A Renz | Chief Financial Officer | 5,289 | $5.86 | $892.1M | -57.38% | +0.56% | $31.0K | -1.76% | — | Sell Now |
| Aug 20, 2024 | Sell | ARDX | Elizabeth A Grammer | — | 7,089 | $5.86 | $892.1M | -57.38% | +0.56% | $41.5K | -3.55% | — | Sell Now |
| Aug 20, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 7,219 | $5.86 | $892.1M | -57.38% | +0.56% | $42.3K | -1.40% | — | Sell Now |
| Aug 20, 2024 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 7,412 | $5.86 | $892.1M | -57.38% | +0.56% | $43.4K | -2.30% | — | Sell Now |
| Aug 20, 2024 | Sell | ARDX | Michael Raab | President & CEO | 32,225 | $5.86 | $892.1M | -57.38% | +0.56% | $188.8K | -2.56% | — | Sell Now |
| Aug 16, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 61,014 | $4.30 | $892.1M | -57.38% | +0.56% | $262.1K | -2.62% | 10b5-1 | Sell Now |
| Aug 12, 2024 | Sell | ARDX | Michael Raab | President & CEO | 1,229 | $5.71 | $892.1M | -57.38% | +0.56% | $7.0K | -0.10% | 10b5-1 | Sell Now |
| Jul 29, 2024 | Sell | ARDX | Michael Raab | President & CEO | 60,000 | $3.32 | $892.1M | -57.38% | +0.56% | $199.0K | +0.00% | 10b5-1 | Sell Now |
| Jul 15, 2024 | Sell | ARDX | Michael Raab | President & CEO | 7,500 | $5.97 | $892.1M | -57.38% | +0.56% | $44.8K | -0.59% | 10b5-1 | Sell Now |
| Jun 28, 2024 | Sell | ARDX | Michael Raab | President & CEO | 2,310 | $6.59 | $892.1M | -57.38% | +0.56% | $15.2K | -0.18% | 10b5-1 | Sell Now |
| Jun 21, 2024 | Sell | ARDX | Robert Blanks | — | 38,000 | $5.96 | $892.1M | -57.38% | +0.56% | $226.3K | -10.49% | 10b5-1 | Sell Now |
| Jun 13, 2024 | Sell | ARDX | Michael Raab | President & CEO | 70,000 | $3.82 | $892.1M | -57.38% | +0.56% | $267.4K | +0.00% | — | Sell Now |
| Jun 5, 2024 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 245,000 | $5.34 | $892.1M | -57.38% | +0.56% | $1.3M | -2.99% | — | Sell Now |
| Jun 3, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 17,872 | $7.00 | $892.1M | -57.38% | +0.56% | $125.1K | -10.13% | — | Sell Now |
| May 29, 2024 | Sell | ARDX | Michael Raab | President & CEO | 7,500 | $6.72 | $892.1M | -57.38% | +0.56% | $50.4K | -0.59% | 10b5-1 | Sell Now |
| May 21, 2024 | Sell | ARDX | Robert Ora Felsch | — | 3,485 | $7.81 | $892.1M | -57.38% | +0.56% | $27.2K | -3.53% | — | Sell Now |
| May 21, 2024 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 4,794 | $7.81 | $892.1M | -57.38% | +0.56% | $37.4K | -1.29% | — | Sell Now |
| May 21, 2024 | Sell | ARDX | Robert Blanks | — | 4,855 | $7.81 | $892.1M | -57.38% | +0.56% | $37.9K | -1.32% | — | Sell Now |
| May 21, 2024 | Sell | ARDX | Justin A Renz | Chief Financial Officer | 5,167 | $7.81 | $892.1M | -57.38% | +0.56% | $40.4K | -1.69% | — | Sell Now |
| May 21, 2024 | Sell | ARDX | Susan Rodriguez | Chief Commercial Officer | 6,703 | $7.81 | $892.1M | -57.38% | +0.56% | $52.4K | -1.47% | — | Sell Now |
| May 21, 2024 | Sell | ARDX | Elizabeth A Grammer | — | 6,927 | $7.81 | $892.1M | -57.38% | +0.56% | $54.1K | -3.36% | — | Sell Now |
| May 21, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 7,053 | $7.81 | $892.1M | -57.38% | +0.56% | $55.1K | -1.26% | — | Sell Now |
| May 21, 2024 | Sell | ARDX | Michael Raab | President & CEO | 31,484 | $7.81 | $892.1M | -57.38% | +0.56% | $245.9K | -2.40% | — | Sell Now |
| May 14, 2024 | Sell | ARDX | Michael Raab | President & CEO | 3,000 | $7.99 | $892.1M | -57.38% | +0.56% | $24.0K | -0.23% | 10b5-1 | Sell Now |
| May 6, 2024 | Sell | ARDX | Robert Ora Felsch | — | 327,089 | $6.14 | $892.1M | -57.38% | +0.56% | $2.0M | -8.50% | — | Sell Now |
| May 6, 2024 | Sell | ARDX | Elizabeth A Grammer | — | 504,107 | $5.82 | $892.1M | -57.38% | +0.56% | $2.9M | -3.41% | — | Sell Now |
| May 3, 2024 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 69,949 | $5.19 | $892.1M | -57.38% | +0.56% | $363.3K | -1.04% | 10b5-1 | Sell Now |
| May 3, 2024 | Sell | ARDX | Elizabeth A Grammer | — | 45,000 | $9.00 | $892.1M | -57.38% | +0.56% | $405.0K | -14.38% | 10b5-1 | Sell Now |
| Apr 29, 2024 | Sell | ARDX | Michael Raab | President & CEO | 60,000 | $3.70 | $892.1M | -57.38% | +0.56% | $221.8K | +0.00% | 10b5-1 | Sell Now |
| Apr 15, 2024 | Sell | ARDX | Michael Raab | President & CEO | 7,500 | $7.06 | $892.1M | -57.38% | +0.56% | $52.9K | -0.57% | 10b5-1 | Sell Now |
| Apr 1, 2024 | Sell | ARDX | Michael Raab | President & CEO | 1,518 | $7.31 | $892.1M | -57.38% | +0.56% | $11.1K | -0.12% | 10b5-1 | Sell Now |
| Mar 20, 2024 | Sell | ARDX | Elizabeth A Grammer | — | 86,000 | $7.73 | $892.1M | -57.38% | +0.56% | $665.0K | -21.55% | 10b5-1 | Sell Now |
| Mar 15, 2024 | Sell | ARDX | Robert Blanks | — | 1,000 | $8.10 | $892.1M | -57.38% | +0.56% | $8.1K | -0.27% | — | Sell Now |
| Feb 26, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 5,183 | $9.20 | $892.1M | -57.38% | +0.56% | $47.7K | -2.86% | — | Sell Now |
| Feb 20, 2024 | Sell | ARDX | Robert Ora Felsch | — | 2,352 | $8.75 | $892.1M | -57.38% | +0.56% | $20.6K | -1.26% | — | Sell Now |
| Feb 20, 2024 | Sell | ARDX | Elizabeth A Grammer | — | 4,432 | $8.75 | $892.1M | -57.38% | +0.56% | $38.8K | -1.10% | — | Sell Now |
| Feb 20, 2024 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 4,803 | $8.75 | $892.1M | -57.38% | +0.56% | $42.0K | -1.25% | — | Sell Now |
| Feb 20, 2024 | Sell | ARDX | Robert Blanks | — | 5,017 | $8.75 | $892.1M | -57.38% | +0.56% | $43.9K | -1.34% | — | Sell Now |
| Feb 20, 2024 | Sell | ARDX | Justin A Renz | Chief Financial Officer | 5,341 | $8.75 | $892.1M | -57.38% | +0.56% | $46.7K | -1.72% | — | Sell Now |
| Feb 20, 2024 | Sell | ARDX | Susan Rodriguez | Chief Commercial Officer | 6,928 | $8.75 | $892.1M | -57.38% | +0.56% | $60.6K | -1.51% | — | Sell Now |
| Feb 20, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 7,311 | $8.75 | $892.1M | -57.38% | +0.56% | $63.9K | -1.29% | — | Sell Now |
| Feb 20, 2024 | Sell | ARDX | Michael Raab | President & CEO | 22,917 | $8.75 | $892.1M | -57.38% | +0.56% | $200.4K | -1.71% | — | Sell Now |
| Feb 8, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 15,344 | $9.18 | $892.1M | -57.38% | +0.56% | $140.8K | -3.84% | 10b5-1 | Sell Now |
| Jan 8, 2024 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 30,000 | $6.64 | $892.1M | -57.38% | +0.56% | $199.2K | -9.48% | 10b5-1 | Sell Now |
| Dec 26, 2023 | Sell | ARDX | Justin A Renz | Chief Financial Officer | 300,000 | $5.01 | $892.1M | -57.38% | +0.56% | $1.5M | -17.42% | 10b5-1 | Sell Now |
| Dec 18, 2023 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 5,675 | $6.07 | $892.1M | -57.38% | +0.56% | $34.4K | -1.76% | 10b5-1 | Sell Now |
| Dec 14, 2023 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 7,000 | $5.55 | $892.1M | -57.38% | +0.56% | $38.9K | -2.13% | 10b5-1 | Sell Now |
| Dec 11, 2023 | Sell | ARDX | Elizabeth A Grammer | — | 50,000 | $5.08 | $892.1M | -57.38% | +0.56% | $253.9K | -15.35% | 10b5-1 | Sell Now |
| Dec 8, 2023 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 20,000 | $5.27 | $892.1M | -57.38% | +0.56% | $105.5K | -5.73% | 10b5-1 | Sell Now |
| Dec 5, 2023 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 10,272 | $5.00 | $892.1M | -57.38% | +0.56% | $51.4K | -2.86% | 10b5-1 | Sell Now |
| Nov 30, 2023 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 3,000 | $4.50 | $892.1M | -57.38% | +0.56% | $13.5K | -0.83% | 10b5-1 | Sell Now |
| Nov 20, 2023 | Sell | ARDX | Robert Ora Felsch | — | 1,044 | $4.36 | $892.1M | -57.38% | +0.56% | $4.6K | -0.88% | — | Sell Now |
| Nov 20, 2023 | Sell | ARDX | Elizabeth A Grammer | — | 2,384 | $4.36 | $892.1M | -57.38% | +0.56% | $10.4K | -0.73% | — | Sell Now |
| Nov 20, 2023 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 2,581 | $4.36 | $892.1M | -57.38% | +0.56% | $11.3K | -0.96% | — | Sell Now |
| Nov 20, 2023 | Sell | ARDX | Robert Blanks | — | 2,835 | $4.36 | $892.1M | -57.38% | +0.56% | $12.4K | -1.08% | — | Sell Now |
| Nov 20, 2023 | Sell | ARDX | Justin A Renz | Chief Financial Officer | 2,873 | $4.36 | $892.1M | -57.38% | +0.56% | $12.5K | -0.86% | — | Sell Now |
| Nov 20, 2023 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 3,767 | $4.36 | $892.1M | -57.38% | +0.56% | $16.4K | -0.79% | — | Sell Now |
| Nov 20, 2023 | Sell | ARDX | Susan Rodriguez | Chief Commercial Officer | 4,714 | $4.36 | $892.1M | -57.38% | +0.56% | $20.6K | -1.34% | — | Sell Now |
| Nov 20, 2023 | Sell | ARDX | Michael Raab | President & CEO | 11,368 | $4.36 | $892.1M | -57.38% | +0.56% | $49.6K | -1.29% | — | Sell Now |
| Nov 15, 2023 | Sell | ARDX | Laura A Williams | Chief Medical Officer | 25,000 | $4.00 | $892.1M | -57.38% | +0.56% | $100.0K | -8.57% | — | Sell Now |
| Oct 10, 2023 | Sell | ARDX | David P. Rosenbaum | Chief Development Officer | 1,644 | $4.00 | $892.1M | -57.38% | +0.56% | $6.6K | -0.45% | 10b5-1 | Sell Now |